Chicago Partners Investment Group’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-489
Closed -$4K 667
2022
Q3
$4K Hold
489
﹤0.01% 583
2022
Q2
$22K Sell
489
-1
-0.2% -$74 ﹤0.01% 587
2022
Q1
$26K Buy
490
+3
+0.6% +$438 ﹤0.01% 558
2021
Q4
$70K Buy
487
+56
+13% +$20.9K 0.01% 558
2021
Q3
$180K Buy
431
+2
+0.5% +$927 0.01% 555
2021
Q2
$177K Buy
429
+1
+0.2% +$537 0.01% 508
2021
Q1
$240K Buy
428
+9
+2% +$4.64K 0.02% 448
2020
Q4
$226K Buy
419
+143
+52% +$46.9K 0.02% 419
2020
Q3
$69K Buy
276
+71
+35% +$17.6K 0.01% 399
2020
Q2
$72K Buy
205
+33
+19% +$5.49K 0.01% 375
2020
Q1
$28K Hold
172
﹤0.01% 352
2019
Q4
$31K Buy
172
+26
+18% +$3.36K ﹤0.01% 362
2019
Q3
$20K Buy
146
+34
+30% +$4.53K ﹤0.01% 331
2019
Q2
$14K Hold
112
﹤0.01% 320
2019
Q1
$18K Buy
112
+36
+47% +$6.17K ﹤0.01% 311
2018
Q4
$11K Hold
76
﹤0.01% 314
2018
Q3
$10K Buy
+76
New +$31.8K ﹤0.01% 832

Other funds holding AMPE

Chicago Partners Investment Group's AMPE Position: Q4 2022 in Review

Chicago Partners Investment Group sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q4 2022, closing a stake of 489 shares — an estimated $4K sold.

Chicago Partners Investment Group first reported a position in AMPE in Q3 2018 and held it in 17 quarters. The position peaked at $240K in Q1 2021. 32 funds tracked by Wall St. Rank hold AMPE as of Q4 2022.

  • Chicago Partners Investment Group reported no remaining Ampio Pharmaceuticals Inc. position as of Q4 2022 after selling out during the quarter.
  • Chicago Partners Investment Group sold 489 Ampio Pharmaceuticals Inc. shares in Q4 2022, an estimated $4K.
  • Chicago Partners Investment Group first reported a position in Ampio Pharmaceuticals Inc. in Q3 2018 and held it in 17 quarters.
  • Chicago Partners Investment Group's Ampio Pharmaceuticals Inc. position peaked at $240K in Q1 2021.
  • 32 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q4 2022.

Based on Chicago Partners Investment Group's 13F filing for Q4 2022, filed 9 Feb 2023.